IL158285A0 - Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-base assay for determination of immune responses against oxidized low density lipoprotein - Google Patents

Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-base assay for determination of immune responses against oxidized low density lipoprotein

Info

Publication number: IL158285A0
Authority: IL; Israel
Prior art keywords: peptide; atherosclerosis; determination; development; treatment
Prior art date: 2001-04-05

Application number

IL15828502A

Other languages

English (en)

Original Assignee

Forskarpatent I Syd Ab Cedars

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-04-05

Filing date

2002-04-05

Publication date

2004-05-12

2001-04-05 Priority claimed from SE0101232A external-priority patent/SE0101232D0/xx

2002-04-05 Application filed by Forskarpatent I Syd Ab Cedars filed Critical Forskarpatent I Syd Ab Cedars

2004-05-12 Publication of IL158285A0 publication Critical patent/IL158285A0/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/775—Apolipopeptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Immunology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Zoology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Genetics & Genomics (AREA)
Gastroenterology & Hepatology (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Vascular Medicine (AREA)
Marine Sciences & Fisheries (AREA)
Hematology (AREA)
Toxicology (AREA)
Epidemiology (AREA)
Urology & Nephrology (AREA)
Diabetes (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Investigating Or Analysing Biological Materials (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicinal Preparation (AREA)
Medicines Containing Plant Substances (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

IL15828502A 2001-04-05 2002-04-05 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-base assay for determination of immune responses against oxidized low density lipoprotein IL158285A0 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
SE0101232A SE0101232D0 (sv)	2001-04-05	2001-04-05	Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based elisa for determination of immune responses against oxidized low density liprotein
SE0103754A SE0103754L (sv)	2001-04-05	2001-11-09	Peptider från apolipoprotein B, användning därav immunisering, diagnosmetod eller terapeutisk behandling av ischemiska kardiovaskulära sjukdomar, samt farmaceutisk komposition och vaccin innehållande sådan peptid
PCT/SE2002/000679 WO2002080954A1 (en)	2001-04-05	2002-04-05	Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein

Publications (1)

Publication Number	Publication Date
IL158285A0 true IL158285A0 (en)	2004-05-12

Family

ID=26655437

Family Applications (4)

Application Number	Title	Priority Date	Filing Date
IL15828502A IL158285A0 (en)	2001-04-05	2002-04-05	Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-base assay for determination of immune responses against oxidized low density lipoprotein
IL158285A IL158285A (en)	2001-04-05	2003-10-07	Peptides for preparing medicament for immuno- therapy of atherosclerosis and development of peptide-base assay for determination of immune responses against oxidized low density lipoprotein
IL188286A IL188286A0 (en)	2001-04-05	2007-12-20	Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
IL195356A IL195356A0 (en)	2001-04-05	2008-11-18	Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein

Family Applications After (3)

Application Number	Title	Priority Date	Filing Date
IL158285A IL158285A (en)	2001-04-05	2003-10-07	Peptides for preparing medicament for immuno- therapy of atherosclerosis and development of peptide-base assay for determination of immune responses against oxidized low density lipoprotein
IL188286A IL188286A0 (en)	2001-04-05	2007-12-20	Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
IL195356A IL195356A0 (en)	2001-04-05	2008-11-18	Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein

Country Status (18)

Country	Link
EP (42)	EP2289915A1 (et)
JP (6)	JP2004529143A (et)
CN (4)	CN103122031B (et)
AT (2)	ATE510851T1 (et)
AU (1)	AU2002246484B8 (et)
BR (1)	BR0208685A (et)
CA (3)	CA2443223C (et)
CY (1)	CY1108817T1 (et)
DE (1)	DE60230029D1 (et)
DK (3)	DK2006301T3 (et)
EE (2)	EE200300487A (et)
ES (2)	ES2317999T3 (et)
IL (4)	IL158285A0 (et)
PL (4)	PL400308A1 (et)
PT (1)	PT1383526E (et)
RU (1)	RU2296582C2 (et)
SE (1)	SE0103754L (et)
WO (1)	WO2002080954A1 (et)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030105003A1 (en)	2001-04-05	2003-06-05	Jan Nilsson	Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
SE0103754L (sv) *	2001-04-05	2002-10-06	Forskarpatent I Syd Ab	Peptider från apolipoprotein B, användning därav immunisering, diagnosmetod eller terapeutisk behandling av ischemiska kardiovaskulära sjukdomar, samt farmaceutisk komposition och vaccin innehållande sådan peptid
WO2003026492A2 (en)	2001-09-28	2003-04-03	Esperion Therapeutics Inc.	Prevention and treatment of restenosis by local administration of drug
SE0302312D0 (sv) *	2002-10-04	2003-08-27	Forskarpatent I Syd Ab	Peptide-based passive immunization therapy for treatment of atherosclerosis
WO2004030607A2 (en) *	2002-10-04	2004-04-15	Forskarpatent I Syd Ab	Peptide-based passive immunization therapy for treatment of atherosclerosis
SE0302422D0 (sv)	2003-09-11	2003-09-11	Forskarpatent I Syd Ab	Peptide-based immunization therapy for treatment of atherosclerosis
SE0400683D0 (sv)	2004-03-19	2004-03-19	Forskarpatent I Syd Ab	Use of modified extracellular matrix proteins in diagnosis and treatment of a atherosclerosis
EP1732383A4 (en)	2004-04-06	2007-05-02	Cedars Sinai Medical Center	PREVENTION AND TREATMENT OF VASCULAR DISEASES WITH RECOMBINANT ADENO ASSOCIATED VIRUS VECTORS THAT CODE APOLIPOPROTEIN A-I AND APOLIPOPROTEIN A-I MILANO
EP1797893B1 (en)	2004-04-15	2010-04-07	Athera Biotechnologies Ab	Antibodies against phosphorylcholine conjugates
EP1676602A1 (en) *	2005-01-04	2006-07-05	Institut National De La Sante Et De La Recherche Medicale (Inserm)	Continuous administration of epitopes derived from protein present in atherosclerotic plaque for the treatment of atherosclerosis
GB0517878D0 (en)	2005-09-02	2005-10-12	Bioinvent Int Ab	Immunotherapeutic treatment
WO2008080030A2 (en) *	2006-12-22	2008-07-03	Abbott Laboratories	Cardiovascular autoimmune disease panel and methods of using same
WO2008104194A1 (en) *	2007-02-28	2008-09-04	Bioinvent International Ab	Oxidized ldl and antibodies thereto for the treatment of atheroscleroti c plaques
AR065718A1 (es)	2007-03-15	2009-06-24	Novartis Ag	Compuestos heterociclicos nitrogenados,utiles en el diagnostico y tratamiento de trastornos hiperproliferativos.
US9359633B2 (en) *	2007-11-05	2016-06-07	Nordic Bioscience A/S	Biochemical markers for CVD risk assessment
US20100041663A1 (en)	2008-07-18	2010-02-18	Novartis Ag	Organic Compounds as Smo Inhibitors
US20110287955A1 (en) *	2008-08-15	2011-11-24	National University Corporation Chiba University	Polypeptide marker for diagnosis of arteriosclerosis, method for detection of arteriosclerosis by using the maker or the like, and kit for diagnosis of arteriosclerosis
EP2499488A1 (en)	2009-11-14	2012-09-19	Kuang-Yuh Chyu	Immunomodulatory methods and systems for treatment and/or prevention of atherosclerosis
US8506964B2 (en)	2010-02-05	2013-08-13	Cardiovax, Llc	Fusion proteins and related compositions, methods and systems for treatment and/or prevention of atherosclerosis
US20130142760A1 (en)	2010-08-18	2013-06-06	Cedars-Sinai Medical Center	Atherosclerosis inhibition via modulation of monocyte-macrophage phenotype using apo a-i milano gene transfer
WO2012065135A2 (en)	2010-11-12	2012-05-18	Cedars-Sinai Medical Center	Immunomodulatory compositions, methods and systems comprising immunogenic fragments of apob100
CN103608035A (zh) *	2010-11-12	2014-02-26	赛达斯西奈医疗中心	用于治疗和/或预防高血压的免疫调节方法和系统
WO2012065133A1 (en)	2010-11-12	2012-05-18	Cedars-Sinai Medical Center	Immunomodulatory methods and systems for treatment and/or prevention of aneurysms
KR101947758B1 (ko)	2011-08-09	2019-02-14	아테라 바이오테크놀로지스 아베	포스포릴콜린에 대한 신규 항체
WO2013022968A1 (en)	2011-08-09	2013-02-14	Athera Biotechnologies Ab	Antibodies binding to phosphorylcholine (pc) and/or pc conjugates
RU2495048C1 (ru) *	2012-04-18	2013-10-10	Андрей Валентинович Исаев	Пептид, обладающий антиатеросклеротическим действием и композиция для профилактики и лечения атеросклероза сосудов
US10087234B2 (en)	2012-11-06	2018-10-02	Les Hopitaux Universitaires De Geneve	Mimetic peptides
CN103520713B (zh) *	2013-10-16	2015-10-28	西北农林科技大学	一种ApoB100酵母重组疫苗及其制备方法和应用
CN103860470A (zh) *	2014-03-05	2014-06-18	贵州中泰生物科技有限公司	一种口服高密度脂蛋白脂质体的制备方法
CN105315364B (zh) *	2014-06-17	2018-09-18	广州文瑞生物科技有限公司	胶原蛋白vi疫苗预防动脉粥样硬化
CN108135973B (zh) *	2015-05-19	2021-10-19	拉·约拉过敏反应及免疫医学研究所	调节炎症应答及治疗不良心血管事件、病和粥样硬化的人apob100表位、方法和用途
US10858422B2 (en)	2016-05-31	2020-12-08	Abcentra, Llc	Methods for treating systemic lupus erythematosus with an anti-apolipoprotein B antibody
CN108478817B (zh) *	2018-03-16	2020-10-27	北京大学	一种动脉粥样硬化检测试剂及其制备方法
JP7357646B2 (ja)	2018-05-29	2023-10-06	アブセントラ，エルエルシー	乾癬の治療のための組成物及び方法
CA3129373A1 (en)	2018-05-29	2019-12-05	Abcentra, Llc	Compositions and methods for treatment of rheumatoid arthritis and accelerated atherosclerosis
CN115025210B (zh) *	2021-03-05	2025-09-05	香港中文大学	减少动脉粥样硬化进展的肽疫苗组合物和药物制剂
CN115025211A (zh) *	2021-11-02	2022-09-09	南京理工大学	用于动脉粥样硬化治疗的纳米疫苗及其制备方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4970144A (en)	1984-12-31	1990-11-13	International Genetic Engineering	Peptide fragments of human apolipoprotein, type-specific antibodies and methods of use
US5972890A (en)	1988-05-02	1999-10-26	New England Deaconess Hospital Corporation	Synthetic peptides for arterial imaging
WO1993018067A1 (en) *	1992-03-06	1993-09-16	Abbott Laboratories	Immunocapture assay for direct quantitation of specific lipoprotein cholesterol levels
WO1994000592A1 (en) *	1992-06-26	1994-01-06	Exocell, Inc.	Monoclonal antibodies against glycated low density lipoprotein
EP0671926B1 (en) *	1992-08-11	2002-11-13	President And Fellows Of Harvard College	Immunomodulatory peptides
KR0185334B1 (ko)	1995-11-02	1999-04-01	김은영	인간 혈장 아포지단백질 비-100에 결합하는 생쥐 항체를 암호하는 씨디엔에이
GB9609702D0 (en) *	1996-05-09	1996-07-10	Royal Free Hosp School Med	Anticoagulant peptides
GB9620153D0 (en) *	1996-09-27	1996-11-13	Univ Strathclyde	Non-naturally occurring lipoprotein particle
GB9705831D0 (en) *	1997-03-20	1997-05-07	Univ Leicester	Oxidised ldl
US6635623B1 (en) *	1997-06-13	2003-10-21	Baylor College Of Medicine	Lipoproteins as nucleic acid vectors
US6225070B1 (en)	1997-08-07	2001-05-01	The Regents Of The University Of California	Antibodies to oxidation-specific epitopes on lipoprotein and methods for their use in detecting, monitoring and inhibiting the growth of atheroma
US6156315A (en) *	1997-10-10	2000-12-05	The Trustees Of Columbia University In The City Of New York	Method for inhibiting the binding of low density lipoprotein to blood vessel matrix
EP0911344B1 (en) *	1997-10-15	2004-03-03	Fujirebio Inc.	Anti-Apo-B-48 monoclonal antibody, hybridoma, and methods of use
WO1999046598A1 (en) *	1998-03-10	1999-09-16	The Regents Of The University Of California	Methods and tools for identifying compounds which modulate atherosclerosis by impacting ldl-proteoglycan binding
WO2000002920A1 (en) *	1998-07-13	2000-01-20	University Of Otago	Inhibition of lipoprotein formation
IL126447A (en) *	1998-10-04	2004-09-27	Vascular Biogenics Ltd	An immune preparation that confers tolerance in oral administration and its use in the prevention and / or treatment of atherosclerosis
DE60045869D1 (de) *	1999-10-26	2011-06-01	Univ California	Reagenzien und verfahren für diagnose, 'imaging' und behandlung von atherosklerotischen krankheiten
AU2001233114A1 (en) *	2000-02-04	2001-08-14	Aeomica, Inc.	Methods and apparatus for predicting, confirming, and displaying functional information derived from genomic sequence
ATE265860T1 (de) *	2000-03-03	2004-05-15	Glaxosmithkline Biolog Sa	Impstoff zur behandlung von atherosclerosis
SE0000855D0 (sv) *	2000-03-15	2000-03-15	Karolinska Innovations Ab	Antigenic composition useful as a vaccine against atherosclerosis
GB0017641D0 (en) *	2000-07-18	2000-09-06	Medigene Oy	Peptides and their use
EP1186299A1 (en) *	2000-09-12	2002-03-13	Universitair Medisch Centrum Utrecht	The diagnosis, prevention, and/or succesful treatment of atherosclerosis, infectious diseases, and disturbances in the immune system
AU2002243382A1 (en) *	2000-10-25	2002-06-24	Vincent Agnello	Method of inhibiting infection by HCV, other flaviviridae viruses, and any other virus that complexes to low density lipoprotein or to very low density lipoprotein in blood preventing viral entry into a cell
AU2002241603A1 (en) *	2000-11-10	2002-06-03	University Of Utah Research Foundation	Carrier system for specific artery wall gene delivery
SE0103754L (sv) *	2001-04-05	2002-10-06	Forskarpatent I Syd Ab	Peptider från apolipoprotein B, användning därav immunisering, diagnosmetod eller terapeutisk behandling av ischemiska kardiovaskulära sjukdomar, samt farmaceutisk komposition och vaccin innehållande sådan peptid
MXPA03010456A (es) *	2001-05-15	2004-12-06	Japan Inmunores Lab Co Ltd	Peptidos reactivos a lipoproteina de alta densidad.
JP2005504025A (ja) *	2001-07-20	2005-02-10	アイトゲネシシェテクニシェホッヒシュルチューリッヒ（エーテーハーツェット）	スルフォネート化またはスルフェート化アミノ酸から誘導された生物学的薬剤の使用法と組成物

2001
- 2001-11-09 SE SE0103754A patent/SE0103754L/xx not_active Application Discontinuation
2002
- 2002-04-05 EP EP10180172A patent/EP2289915A1/en not_active Withdrawn
- 2002-04-05 EP EP10181167A patent/EP2289925A1/en not_active Withdrawn
- 2002-04-05 EP EP10181253.5A patent/EP2289934B1/en not_active Expired - Lifetime
- 2002-04-05 EP EP10180026A patent/EP2295457A1/en not_active Withdrawn
- 2002-04-05 EP EP07119130A patent/EP1918300A3/en not_active Withdrawn
- 2002-04-05 AT AT08151489T patent/ATE510851T1/de not_active IP Right Cessation
- 2002-04-05 EP EP10180828A patent/EP2289921A1/en not_active Withdrawn
- 2002-04-05 EP EP10180188A patent/EP2289916A1/en not_active Withdrawn
- 2002-04-05 EP EP10180099A patent/EP2295458A1/en not_active Withdrawn
- 2002-04-05 EP EP08151489A patent/EP2006301B1/en not_active Expired - Lifetime
- 2002-04-05 EP EP10180199A patent/EP2289918A1/en not_active Withdrawn
- 2002-04-05 CN CN201210322795.9A patent/CN103122031B/zh not_active Expired - Lifetime
- 2002-04-05 EP EP08167531A patent/EP2147929A3/en not_active Ceased
- 2002-04-05 CN CN2007101953989A patent/CN101284874B/zh not_active Expired - Lifetime
- 2002-04-05 ES ES02714667T patent/ES2317999T3/es not_active Expired - Lifetime
- 2002-04-05 IL IL15828502A patent/IL158285A0/xx unknown
- 2002-04-05 DK DK08151489.5T patent/DK2006301T3/da active
- 2002-04-05 PL PL400308A patent/PL400308A1/pl unknown
- 2002-04-05 EP EP10180184A patent/EP2295462A1/en not_active Withdrawn
- 2002-04-05 EE EEP200300487A patent/EE200300487A/et unknown
- 2002-04-05 EP EP10180823A patent/EP2289919A1/en not_active Withdrawn
- 2002-04-05 EP EP10180156A patent/EP2295459A1/en not_active Withdrawn
- 2002-04-05 EP EP10180091A patent/EP2305706A1/en not_active Withdrawn
- 2002-04-05 EP EP10180193A patent/EP2289917A1/en not_active Withdrawn
- 2002-04-05 CA CA2443223A patent/CA2443223C/en not_active Expired - Lifetime
- 2002-04-05 DK DK02714667T patent/DK1383526T3/da active
- 2002-04-05 EP EP10181188A patent/EP2289927A1/en not_active Withdrawn
- 2002-04-05 EP EP10181217A patent/EP2289931A1/en not_active Withdrawn
- 2002-04-05 EP EP10180826A patent/EP2289920A1/en not_active Withdrawn
- 2002-04-05 EP EP10181227A patent/EP2289932A1/en not_active Withdrawn
- 2002-04-05 EP EP08167533A patent/EP2147930A3/en not_active Withdrawn
- 2002-04-05 CA CA2827167A patent/CA2827167A1/en not_active Abandoned
- 2002-04-05 EP EP10181273A patent/EP2289935A1/en not_active Withdrawn
- 2002-04-05 EP EP10180176A patent/EP2305708A1/en not_active Withdrawn
- 2002-04-05 CN CN028089405A patent/CN1505525B/zh not_active Expired - Fee Related
- 2002-04-05 EP EP10180115A patent/EP2305707A1/en not_active Withdrawn
- 2002-04-05 PL PL391615A patent/PL217858B1/pl unknown
- 2002-04-05 EP EP10181213A patent/EP2289930A1/en not_active Withdrawn
- 2002-04-05 EP EP10180111A patent/EP2289914A1/en not_active Withdrawn
- 2002-04-05 ES ES10181267.5T patent/ES2546293T3/es not_active Expired - Lifetime
- 2002-04-05 RU RU2003132443/15A patent/RU2296582C2/ru active
- 2002-04-05 EP EP10180162.9A patent/EP2295460B1/en not_active Expired - Lifetime
- 2002-04-05 EP EP02714667A patent/EP1383526B1/en not_active Expired - Lifetime
- 2002-04-05 DE DE60230029T patent/DE60230029D1/de not_active Expired - Lifetime
- 2002-04-05 EP EP10180838A patent/EP2289923A1/en not_active Withdrawn
- 2002-04-05 PL PL385189A patent/PL215401B1/pl unknown
- 2002-04-05 DK DK10181267.5T patent/DK2295464T3/en active
- 2002-04-05 CA CA2606839A patent/CA2606839C/en not_active Expired - Lifetime
- 2002-04-05 CN CNA2009100095655A patent/CN101486766A/zh active Pending
- 2002-04-05 EP EP10181245A patent/EP2289933A1/en not_active Withdrawn
- 2002-04-05 EP EP10180106A patent/EP2289912A1/en not_active Withdrawn
- 2002-04-05 EP EP10181203A patent/EP2289929A1/en not_active Withdrawn
- 2002-04-05 WO PCT/SE2002/000679 patent/WO2002080954A1/en not_active Ceased
- 2002-04-05 EP EP10181173A patent/EP2289926A1/en not_active Withdrawn
- 2002-04-05 AT AT02714667T patent/ATE415423T1/de active
- 2002-04-05 EP EP08158141A patent/EP2147928A3/en not_active Withdrawn
- 2002-04-05 EP EP10180845A patent/EP2289924A1/en not_active Withdrawn
- 2002-04-05 EP EP10180109A patent/EP2289913A1/en not_active Withdrawn
- 2002-04-05 BR BR0208685-9A patent/BR0208685A/pt not_active Application Discontinuation
- 2002-04-05 EP EP10181263A patent/EP2295463A1/en not_active Withdrawn
- 2002-04-05 PL PL02367301A patent/PL367301A1/xx unknown
- 2002-04-05 JP JP2002578993A patent/JP2004529143A/ja not_active Withdrawn
- 2002-04-05 EP EP08167532A patent/EP2147680A3/en not_active Withdrawn
- 2002-04-05 EP EP10181196A patent/EP2289928A1/en not_active Withdrawn
- 2002-04-05 EE EEP200700052A patent/EE200700052A/et unknown
- 2002-04-05 EP EP10180168A patent/EP2295461A1/en not_active Withdrawn
- 2002-04-05 PT PT02714667T patent/PT1383526E/pt unknown
- 2002-04-05 EP EP10180835A patent/EP2289922A1/en not_active Withdrawn
- 2002-04-05 EP EP10181267.5A patent/EP2295464B1/en not_active Expired - Lifetime
- 2002-04-05 AU AU2002246484A patent/AU2002246484B8/en not_active Expired
2003
- 2003-10-07 IL IL158285A patent/IL158285A/en active IP Right Grant
2007
- 2007-12-20 IL IL188286A patent/IL188286A0/en unknown
2008
- 2008-01-25 JP JP2008015545A patent/JP2008169215A/ja not_active Withdrawn
- 2008-11-18 IL IL195356A patent/IL195356A0/en unknown
2009
- 2009-02-24 CY CY20091100202T patent/CY1108817T1/el unknown
- 2009-06-02 JP JP2009133383A patent/JP5270456B2/ja not_active Expired - Fee Related
2010
- 2010-10-26 JP JP2010239478A patent/JP5300820B2/ja not_active Expired - Lifetime
- 2010-10-26 JP JP2010239477A patent/JP5300819B2/ja not_active Expired - Lifetime
2013
- 2013-02-25 JP JP2013034312A patent/JP5613890B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
EP2289921A1 (en)	2011-03-02
CN1505525A (zh)	2004-06-16
IL188286A0 (en)	2008-03-20
EP2289927A1 (en)	2011-03-02
EP2289932A1 (en)	2011-03-02
EP2295458A1 (en)	2011-03-16
AU2002246484A1 (en)	2002-10-21
CN101284874A (zh)	2008-10-15
EP2295457A1 (en)	2011-03-16
EP1383526A1 (en)	2004-01-28
EP2289922A1 (en)	2011-03-02
EP2147928A2 (en)	2010-01-27
EP2147680A3 (en)	2010-04-14
RU2003132443A (ru)	2005-02-27
PL217858B1 (pl)	2014-08-29
EP2295459A1 (en)	2011-03-16
DK2295464T3 (en)	2015-08-17
EP2289925A1 (en)	2011-03-02
EP2289934B1 (en)	2013-11-13
ES2317999T3 (es)	2009-05-01
CA2606839A1 (en)	2002-10-17
AU2002246484B2 (en)	2007-04-19
EP2305706A1 (en)	2011-04-06
EP2289930A1 (en)	2011-03-02
ES2546293T3 (es)	2015-09-22
DE60230029D1 (de)	2009-01-08
EP2147930A2 (en)	2010-01-27
PL367301A1 (en)	2005-02-21
EP2295462A1 (en)	2011-03-16
CY1108817T1 (el)	2014-04-09
SE0103754L (sv)	2002-10-06
EP2147929A2 (en)	2010-01-27
CN101284874B (zh)	2012-10-03
EP2006301B1 (en)	2011-05-25
EP2305707A1 (en)	2011-04-06
CA2443223A1 (en)	2002-10-17
EP2295460A1 (en)	2011-03-16
CN103122031B (zh)	2015-07-22
EP2289920A1 (en)	2011-03-02
EP2289914A1 (en)	2011-03-02
JP2008169215A (ja)	2008-07-24
SE0103754D0 (sv)	2001-11-09
PT1383526E (pt)	2009-02-27
EP2295464A1 (en)	2011-03-16
EP2289929A1 (en)	2011-03-02
EP1918300A3 (en)	2009-06-17
IL195356A0 (en)	2009-08-03
EP1383526B1 (en)	2008-11-26
EP2289919A1 (en)	2011-03-02
EP2147929A3 (en)	2010-04-14
BR0208685A (pt)	2004-03-30
EP2006301A1 (en)	2008-12-24
EP2289926A1 (en)	2011-03-02
EP2289923A1 (en)	2011-03-02
JP5270456B2 (ja)	2013-08-21
EP2289935A1 (en)	2011-03-02
JP2011063598A (ja)	2011-03-31
EE200700052A (et)	2008-08-15
EP2295460B1 (en)	2015-06-03
CA2443223C (en)	2013-11-26
JP5613890B2 (ja)	2014-10-29
IL158285A (en)	2009-12-24
EP2289916A1 (en)	2011-03-02
ATE415423T1 (de)	2008-12-15
EP2295464B1 (en)	2015-06-03
DK1383526T3 (da)	2009-03-30
EP2289924A1 (en)	2011-03-02
CN101486766A (zh)	2009-07-22
CN1505525B (zh)	2012-11-07
EP2295461A1 (en)	2011-03-16
EP2289913A1 (en)	2011-03-02
EP2289912A1 (en)	2011-03-02
EP2147680A2 (en)	2010-01-27
EP2289917A1 (en)	2011-03-02
EP1918300A2 (en)	2008-05-07
EP2289928A1 (en)	2011-03-02
WO2002080954A1 (en)	2002-10-17
CA2827167A1 (en)	2002-10-17
DK2006301T3 (da)	2011-09-12
JP2013144687A (ja)	2013-07-25
JP5300819B2 (ja)	2013-09-25
EE200300487A (et)	2004-02-16
PL215401B1 (pl)	2013-12-31
EP2147930A3 (en)	2010-04-14
JP2009191078A (ja)	2009-08-27
EP2147928A3 (en)	2010-04-14
EP2305708A1 (en)	2011-04-06
JP5300820B2 (ja)	2013-09-25
EP2289918A1 (en)	2011-03-02
JP2011068654A (ja)	2011-04-07
CN103122031A (zh)	2013-05-29
EP2289933A1 (en)	2011-03-02
ATE510851T1 (de)	2011-06-15
PL400308A1 (pl)	2012-12-17
RU2296582C2 (ru)	2007-04-10
EP2289931A1 (en)	2011-03-02
JP2004529143A (ja)	2004-09-24
AU2002246484B8 (en)	2007-06-14
EP2289934A1 (en)	2011-03-02
CA2606839C (en)	2015-06-09
EP2295463A1 (en)	2011-03-16
EP2289915A1 (en)	2011-03-02

Publication	Publication Date	Title
IL188286A0 (en)	2008-03-20	Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
AT500379A3 (de)	2009-02-15	Tau-proteine
NO872473L (no)	1988-08-11	Peptidblanding og fremgangsmaate ved paavisning av antistoffer mot htlv-iii.
CY1112229T1 (el)	2015-12-09	Αντισωματα κατευθυνομενα εναντι οξειδωμενης απολιποπρωτεϊνης β
DE69635582D1 (de)	2006-01-19	Diagnostika und behandlungen von peridontalen erkrankungen
DK1167389T3 (da)	2007-11-12	Antistoffer mod SEMP1-proteinet, fremgangsmåde til fremstilling heraf samt anvendelse deraf
EP1411962A4 (en)	2005-02-02	TREATMENT OF PANCREATIC CANCER WITH A MONOCLONAL ANTIBODY
BR9710975A (pt)	2000-10-24	Genes de proteìna de adesão de superfìcie exposta de 120 kda imunodominante de ehrlichia chaffeensis
IL160533A0 (en)	2004-07-25	Methods of screening molecules that are used to prevent cardiovascular diseases
PT723552E (pt)	2003-02-28	Oligopeptidos derivados de fragmentos de proteina reactiva c
WO2004030607A3 (en)	2004-06-24	Peptide-based passive immunization therapy for treatment of atherosclerosis
AU2003225900A1 (en)	2003-10-08	Antibody disulfide isomers, use thereof, and methods of analyzing same
ATE245661T1 (de)	2003-08-15	Natürliche menschliche igm antikörper
BRPI0216033B8 (pt)	2021-05-25	"terapia de imunização à base de peptídio para tratamento de arteriosclerose"
ATE329898T1 (de)	2006-07-15	Kombinationspräparat zur therapie von immunologischen erkrankungen
WO2002023202A3 (en)	2003-05-22	Method to identify antibody targets based on mass spectrometry (maldi-tof)
SE0202959D0 (sv)	2002-10-04	Peptide-Base passive immunization therapy for treatment of atherosclerosis